Managers' transactions

Nightingale Health Plc – Managers’ transactions – Olli Karhi

Jul 04, 2024
Press releases

Summary of Financial Year 7/2023 - 6/2024: Nightingale Health achieved several breakthroughs in adopting the company’s technology in healthcare

Jul 03, 2024
Company releases

Inside Information: 23andMe and Nightingale Health Announce Strategic Collaboration to Pilot Blood Biomarker Panel

Jun 28, 2024
Company releases

Inside information: Nightingale Health and Boston Heart Diagnostics enter strategic partnership to sell Nightingale’s Health Check in the United States

Jun 28, 2024
Press releases

Nightingale Health and ZOE expand research collaboration to include self-collected blood samples

Jun 27, 2024
Press releases

Nightingale Health acquires all intellectual property assets of the Velvet™ blood collection device and secures its position as the sole provider of a fully integrated remote health check solution

Jun 27, 2024
Flagging notifications

Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Cor Group Oy)

Jun 18, 2024
Flagging notifications

Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Pasi Soininen)

Jun 18, 2024
Flagging notifications

Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Teemu Suna)

Jun 18, 2024
Flagging notifications

Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Antti Kangas)

Jun 18, 2024
Company releases

Conversion of Nightingale Health Plc’s Series A shares to Series B shares

Jun 11, 2024
Press releases

Health check based on advanced blood analysis technology builds a better foundation for public health

Jun 06, 2024
Company releases

Nightingale Health’s Board of Directors extended the subscription period of employee option rights

May 23, 2024
Press releases

Nightingale Health launches new website aligned with the B2B and B2G strategy

May 21, 2024
Company releases

Inside information: Nightingale Health achieves one of its business targets for this financial year by winning contracts in medical research with a total contract value of at least EUR 3.2 million

Apr 25, 2024